Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical pethidine for postoperative bladder spasm after ureteric reimplantation in children
ACTRN12616001388404Phase 4Not yet recruiting
- Sponsor
- Princess Margaret Cancer Centre
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pethidine in cystospasm (2 arms), sponsored by Princess Margaret Cancer Centre. Primary endpoint: Pain score. Planned start Nov 2016; status: not yet recruiting.
02
Drugs
pethidine
03
Conditions
cystospasm
Beyond the preview
Go deeper on ACTRN12616001388404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001388404.